Editors
About Us
Our Supporters
Contact Us
Subscribe Now!
Home
Articles
News
Announcements
Events
Letters
Search:
Trending Topics
Delaware
Insurance and Risk Management
Outsourcing
Compliance Programs
Campaign Finance Law
Alien Tort Claims Act
Partnering with Law Firms and Service Providers
Defense Counsel Organizations
Judicial Compensation
Corporate Securities and Finance
The EU, Germany and Brussels
Corporate Secretaries and Corporate Governance
Ethics
Managing Litigation Costs
Southeast
more Topics
Home
Healthcare-Life Sciences
Buyers And Sellers Beware – Federal And State Antitrust Authorities Heighten Scrutiny Of Healthcare Provider M&A
Scott B. Murray
Sills Cummis & Gross P.C.
Science And The Law Are Equal Partners In IP Practice
Steven G. Davis
McCarter & English, LLP
The FDA’s Efforts To Regulate Dietary Supplements, Then And Now
Theodora McCormick
Sills Cummis & Gross P.C.
Six Important Strategies To Reduce The Royalty Burden For A Pharmaceutical Product
Lori M. Waldron
Sills Cummis & Gross P.C.
